Target intelligence / Profile preview

RNA, U4 small nuclear 36, pseudogene (RNU4-36P)

Target
RNU4-36P
Molecular classification
Other (Pseudogene, processed non-coding RNA)
01

Overview

RNU4-36P is a pseudogene belonging to the U4 small nuclear RNA gene family. U4 snRNAs are crucial for spliceosomal activity and proper splicing of precursor mRNA, but pseudogenes like RNU4-36P represent non-functional genetic elements typically arising from duplication events or retrotransposition[2][5]. Unlike functional U4 snRNAs—for example, RNU4-2—RNU4-36P does not participate in spliceosome assembly and is not implicated in any biological processes, genetic disorders, or molecular mechanisms relevant to drug development. Pseudogenes are often annotated in genomic databases to indicate gene family relationships and evolutionary history but lack transcriptional activity and clinical relevance. There is no published evidence of RNU4-36P contributing to human disease, being targeted by pharmaceuticals, or serving a function in cell biology[2][5]. The confusion may arise from the functional importance of *active* U4 small nuclear RNAs (such as RNU4-2), which are essential components of the spliceosome and have well-documented roles in neurodevelopmental disease[1][3][4]. However, pseudogenes such as RNU4-36P do not share these properties[2][5]. Whether in the rat or human genome, U4 snRNA pseudogenes have been studied mainly for their truncated or inactive features[5].

Other names
RNA, U4 small nuclear 36, pseudogeneRNU4-36P

Beyond the preview

Go deeper on RNA, U4 small nuclear 36, pseudogene (RNU4-36P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 36, pseudogene (RNU4-36P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call